Skip to main content
Erschienen in: Surgical Endoscopy 12/2020

Open Access 17.01.2020

Laparoscopic transperitoneal and retroperitoneal adrenalectomy: a 20-year, single-institution experience with an analysis of the learning curve and tumor size [lap transper and retroper adrenalectomy]

verfasst von: Aurel Ottlakan, Attila Paszt, Zsolt Simonka, Szabolcs Abraham, Bernadett Borda, Marton Vas, Bela Teleky, Adam Balogh, Gyorgy Lazar

Erschienen in: Surgical Endoscopy | Ausgabe 12/2020

Abstract

Background

The superiority of laparoscopic transperitoneal (TP) versus retroperitoneal (RP) adrenalectomy is an ongoing debate.

Methods

Data from 163 patients (TP: n = 135; RP: n = 28) undergoing minimally invasive adrenalectomy were analyzed. Both operative [intraoperative blood loss, previous abdominal surgery, conversion rate, operative time and tumor size] and perioperative [BMI (body mass index), ASA (American Society of Anesthesiologists) score, time of hospitalization, time of oral intake, histology and postoperative complications] parameters were compared. Both the learning curve (LC) and tumor size were analyzed.

Results

We found significant differences in the mean operative time (p = 0.019) and rate of previous abdominal surgery (p = 0.038) in favor of TP. Significantly larger tumors were removed with TP (p = 0.018). Conversion rates showed no significant difference (p = 0.257). Also, no significant differences were noted for time of hospitalization, intraoperative blood loss and postoperative complications. In terms of the LC, we saw significant differences in previous abdominal surgery (p = 0.015), conversion rate (p = 0.011) and operative time (p = 0.023) in favor of TP. Large (LT) and extra-large tumors (ELT) were involved in 47 lesions (LT: 40 vs. ELT: 7), with a mean tumor size of 71.85 and 141.57 mm, respectively. Mean intraoperative blood loss was 64.47 ml vs. 71.85 ml, time of hospitalization was 5.10 vs. 4.57 days and mean operative time was 76.52 vs. 79.28 min for LT and ELT, respectively.

Conclusion

A shorter operative time and lower conversion rate in favor of TP were noted during the learning curve. TP proved to be more effective in the removal of large-, extra-large and malignant lesions. The RP approach was feasible for smaller, benign lesions, with a more prolonged learning curve.
Hinweise

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Since the introduction of laparoscopic transperitoneal adrenalectomy by Gagner et al. in 1992, several studies have confirmed the advantages of the minimally invasive approach over open adrenalectomy [1]. Minimally invasive adrenalectomy results in a shorter hospital stay and reduced operative time with a decreased rate of perioperative morbidity and mortality. Shortly after the first laparoscopic transperitoneal adrenalectomy, Mercan et al. performed the first endoscopic retroperitoneal adrenalectomy [2] using the posterior approach. The posterior approach has been widely used by Walz et al. and the approach was described as having the main advantage of a direct access to the adrenal glands without interfering with the intraperitoneal organs [3, 4]. In a joint publication by Walz and a South Korean working group, they concluded that the two methods show similarities in some parameters [intraoperative blood loss, tumor size and body mass index (BMI)], although in terms of time of oral intake and operative time, they prefer the posterior retroperitoneal (RP) approach [5, 6]. The greatest among many advantages of the TP method are the safe and simple manipulation during intraoperative laparoscopy and the rapid ligation of the adrenal veins to block catecholamine release. According to some authors, the disadvantages of TP include prolonged operative times even after the learning curve (LC) [7]. When it was first used, the minimally invasive method was reserved for benign, small or moderate-sized adrenal lesions; however, with improved laparoscopic techniques and instrumentation, large (6–10 cm), giant (> 10 cm) and even malignant lesions have been removed with accurate oncological radicality [8, 9]. There is an ongoing debate on the superiority of either TP or RP, which is considerably influenced by the surgeon’s preference. The TP approach may be more feasible for laparoscopic surgeons with its familiar anatomy and wider surgical space [1013], even though possible adhesions after multiple abdominal procedures may lead to difficulties during laparoscopic manipulation, possibly resulting in an increased rate of conversions. According to a recent work by Chen et al., in terms of perioperative factors, ASA (American Society of Anesthesiologists) scores of 3 or 4 and diabetes were independently associated with perioperative complications, while the presence of pheochromocytomas and tumors over 6 cm in size resulted in the highest rate of complications [14]. In the RP approach, the adrenals are directly accessible, without the incursion of intraperitoneal organs, possibly leading to a lower occurrence of postoperative ileus [5]. In recent years, several meta-analyses have compared the two approaches [10, 11] with mixed results. Our aim was to compare the two methods performed during a 20-year period at the same institution, taking operative and perioperative factors into account, with special consideration for learning curves and tumor size.

Materials and methods

Perioperative and mid-term results of minimally invasive adrenalectomy were analyzed between January 1998 and April 2018 at the University of Szeged, Department of Surgery. The retrospective investigation, collection of patient data and ethical approval were granted by the Human Investigation Review Board of the University of Szeged (No. 4485). Minimally invasive procedures were carried out in 163 patients (135 TP and 28 RP procedures). Baseline characteristics (male–female ratio, mean age and BMI) showed no significant difference; thus, the two patient groups were considered homogenous with regard to these characteristics (Table 1). The two approaches were compared in terms of previous abdominal surgery, conversion rate, operative time, intraoperative blood loss, tumor size, histology, time of hospitalization, and early and late postoperative complications. The early postoperative period was defined as the in-patient stay, while the late postoperative period lasted from Month 12 to Month 24 (12 + 9 months). Resected lesions were grouped by size as large tumors (LT: 6–10 cm) or extra-large tumors (ELT: > 10 cm). The two groups were analyzed according to tumor size, histology, complete (R0) resection rate in malignant cases, previous abdominal surgery, conversion rate, intraoperative blood loss, time of hospitalization, operative time, BMI and ASA.
Table 1
Baseline characteristics for TP and RP
 
TP (n = 135) mean ± SD
RP (n = 28) mean ± SD
Males/females
40/95
9/19
Age (years)
57.15 ± 16.7
47.05 ± 27.8
ASA
 1
3 (2.22%)
0 (0%)
 2
51 (37.77%)
6 (23%)
 3
57 (42.22%)
17 (58%)
 4
24 (17.77%)
5 (19%)
BMI (kg/m2)
 Mean
26.09 ± 2.57
25.19 ± 1.3
  ≤ 25
35 (25.92%)
5 (17.85%)
 25–30
62 (45.92%)
13 (46.42%)
 30 ≤ 
38 (28.14%)
10 (35.71%)
TP transperitoneal, RP retroperitoneal, ASA American Society of Anesthesiologists, BMI body mass index
Taking into consideration that significantly fewer procedures were performed using the RP approach, the perioperative parameters of a learning curve (28 procedures for each method) were also compared.
Both TP and RP procedures were carried out by two senior endocrine surgeons with several years of experience in both open and minimally invasive adrenalectomies; thus, operative- and perioperative results were reasonably comparable.

Operative techniques

Laparoscopic transperitoneal adrenalectomy

Surgeries were carried out under general anesthesia. A semilateral positioning (on the left or right side) of the patient was used. By angulating the operating table, the highest level of distance was maintained between the iliac crest and the lower ribs. Three or four utility ports were used during the procedure. After dissection of the adrenal gland using either LigaSure or a Harmonic Scalpel and clipping of the vasculature, the specimen was retrieved in an Endobag. Three extra-large lesions (> 10 cm) were retrieved en bloc through an additional Pfannenstiel incision.

Laparoscopic retroperitoneal adrenalectomy

Surgeries were carried out under general anesthesia. Patients were placed in prone position. 3 ports were inserted during the procedure. After blunt dissection of the lumbar musculature and Gerota’s fascia, the retroperitoneum was insufflated. Additional trocars were placed under finger supervision. Tissue dissection and handling of vessels were carried out by Ultracision and clipping. The fully dissected adrenal was then separated from the upper pole of the kidney. The specimen was retrieved in an Endobag [15].

Statistical analysis

Taking the normal distribution of the population into consideration, the t test and ANOVA were used. The χ2 test and Fischer’s test were employed for categorical variables. A value of p < 0.05 was considered significant. Statistical analysis was carried out using SPSS 25.

Results

During the study period, 135 TP and 28 RP adrenalectomies were performed. Baseline characteristics are shown in Table 1. Even though the rate of previous abdominal surgery was significantly higher for TP [TP: 61 (45.18%) vs. RP: 4 (14%); p = 0.038], the conversion rate was considerably (however, not significantly) higher for RP [TP: 6 (4.44%) vs. RP: 5 (18%); p = 0.257] (Table 2). In terms of operative time, the TP approach proved to be significantly shorter [TP: 78.51 ± 12.38 min vs. RP: 134.5 ± 12.4 min; p = 0.019] with the removal of significantly larger tumors [TP: 56.29 ± 9.02 mm vs. RP: 34.8 ± 11.2 mm; p = 0.018]. 40 large and 7 extra-large tumors were resected during the study. Mean tumor size was 71.85 mm and 141.57 mm for large and extra-large tumors, respectively. There were 25 adenomas, 4 metastases, 4 myelolipomas, 2 hyperplasias, 2 pheochromocytomas, 1 vascular malformation, 1 pseudocyst and 1 adrenocortical carcinoma in the large tumor group. Complete (R0) resections were successfully carried out in all malignant lesion cases (4 metastases and 1 adrenocortical carcinoma). Histology in cases involving extra-large tumors confirmed 3 adrenocortical carcinomas, 1 pheochromocytoma, 1 myelolipoma, 1 neurofibroma and 1 cyst. All three adrenocortical carcinomas proved to be R0 resections. Among the 47 patients, previous abdominal surgery occurred in 12 (30.0%) and 5 (71.42%) cases, laparoscopy was performed in 36 (90.0%) and 7 (100%) patients, mean intraoperative blood loss was 64.47 and 71.85 ml, mean time of hospitalization was 5.10 and 4.57 days, operative time was 76.52 and 79.28 min, mean BMI was 23.45 and 27.87, and mean ASA was 2.62 and 2.42 for large- and extra-large tumors, respectively. There was no significant correlation between removed large tumors/extra-large tumors and duration of surgery.
Table 2
Operative factors for TP and RP
 
TP (n = 135)
RP (n = 28)
p value
Previous abdominal surgery
61 (45.18%)
4 (14%)
0.038
Conversion rate
6 (4.44%)
5 (18%)
0.257
Intraoperative blood loss (ml)
65.7 ± 8.45
50.2 ± 10.78
0.147
Tumor size (mean) (mm)
56.29 ± 9.02
34.8 ± 11.2
0.018
Time of hospitalization (days)
4.25 ± 1.58
4.61 ± 2.24
0.237
Operative time (minutes)
78.51 ± 12.38
134.5 ± 12.4
0.019
TP transperitoneal, RP retroperitoneal
Considering all cases (n = 163), time of hospitalization [TP: 4.25 ± 1.58 vs. RP: 4.61 ± 2.24; p = 0.237] and intraoperative blood loss [65.7 ± 8.45 vs. 50.2 ± 10.78; p = 0.147] showed no significant difference between the two methods (Table 2).
In terms of perioperative analgesia, the administration of NSAIDs (Nonsteroidal Anti-inflammatory Drugs), such as paracetamol, diclofenac and metamizole sodium, proved to be sufficient. Oral intake was started on Postoperative Day 1 in both groups.
Adenoma was found in 65.92% (n = 89) and 64.3% (n = 18) of the TP and RP cases, respectively. Other lesions showed the following pattern in TP cases: metastasis: 8.14% (n = 11); cyst: 5.18% (n = 7); adrenocortical carcinoma: 4.44% (n = 6); myelolipoma: 3.7% (n = 5); hyperplasia: 3.7% (n = 5); vascular malformation: 0.74% (n = 1); neurofibroma: 0.74% (n = 1) and leiomyosarcoma: 0.74% (n = 1). Similar findings were not noted for RP (Table 3). Pheochromocytoma occurred in 6.66% (n = 9) and 17.8% (n = 5) of TP and RP cases, respectively. Altogether, 18 malignant lesions were confirmed in TP cases (11 metastases, 6 adrenocortical carcinomas and 1 leiomyosarcoma). Complete (R0) resection was confirmed in all cases. Early complications occurred in 5 TP cases (splenic injury, fever, postoperative bleeding, severe hypokalemia and ventricular fibrillation) and 4 RP cases (2 cases of postoperative bleeding and 2 cases of severe wound infection) (Table 4). In terms of late onset complications, only one case (1/135; 0.74%) of postoperative abdominal hernia occurred following TP (Table 4).
Table 3
Histology patterns for TP and RP
 
TP (n = 135)
RP (n = 28)
Adenomas
89 (65.92%)
18 (64.3%)
Adrenocortical cc
6 (4.44%)
Leiomyosarcoma
1 (0.74%)
Metastasis
11 (8.14%)
Pheochromocytomas
9 (6.66%)
5 (17.8%)
Cysts
7 (5.18%)
3 (10.7%)
Hyperplasia
5 (3.7%)
2 (7.1%)
Vascular malformation
1 (0.74%)
Neurofibromas
1 (0.74%)
Myelolipomas
5 (3.7%)
TP transperitoneal, RP retroperitoneal
Table 4
Rate of early and late onset complications
 
TP n = 135
RP n = 28
Early complications 1–2 days
 Splenic injury
1
0
 Fever
1
0
 Intraoperative bleeding
1
2
 Severe hyperkalemia
1
0
 Ventricular fibrillation (death)
1
0
 Severe wound infection
0
2
Late complications 12–21 months
 Postoperative abdominal hernia
1
0
TP transperitoneal, RP retroperitoneal
Considering the notable difference between the number of patients in both groups, outcomes for the first 28 procedures in each group were also analyzed. During the LC, a significant difference was noted in terms of previous abdominal surgery [TP: 10 (35.7%) vs. RP: 4 (14%); p = 0.015], conversion rate [TP: 0 vs. RP: 5 (18%); p = 0.011] and operative time [TP: 110 ± 8.1 min vs. RP: 134.5 ± 12.4 min; p = 0.023], both in favor of the TP approach. In terms of operative time, a similar balance was observed during both LCs (Fig. 1), with significantly shorter operative time and significantly larger tumors removed in the TP group (TP: 52.2 ± 4.8 mm vs. RP: 34.8 ± 11.2 mm; p = 0.068). There was no significant difference in terms of intraoperative blood loss or time of hospitalization during the LC (Table 5).
Table 5
Comparison of the learning curve for TP and RP
 
TP (n = 28)
RP (n = 28)
p value
Previous abdominal surgery
10 (35.7%)
4 (14%)
0.015
Conversion rate
0 (0%)
5 (18%)
0.011
Intraoperative blood loss (ml)
58.2 ± 7.3
50.2 ± 10.78
0.235
Tumor size (mean) (mm)
52.2 ± 4.8
34.8 ± 11.2
0.068
Time of hospitalization
4.12
4.61
0.215
Operative time (mean) (minutes)
110 ± 8.1
134.5 ± 12.4
0.023
TP transperitoneal, RP retroperitoneal
The learning curve was analyzed during the first 28 cases in both groups, during which a decreasing trend was confirmed with each method (Fig. 1). In the first 10 procedures, both methods showed a considerable decrease and similar patterns of operative time, with notably longer operative times in RP cases (Fig. 1).

Discussion

In recent years, surgery for adrenal lesions has gradually evolved from the open technique toward the minimally invasive method [1618]. Laparoscopy carries many advantages compared to the traditional approach, such as shorter operative times, reduced postoperative pain, decreased rate of perioperative and long-term complications, and a reduced hospital stay [1, 19]. After it was introduced by Gagner et al., laparoscopic adrenalectomy became the gold standard for the surgical management of adrenal lesions [1]. Laparoscopic transperitoneal and retroperitoneal approaches are undoubtedly the two most popular methods. In the past decade, both have been in the focus of numerous retrospective studies and meta-analyses, which reported no significant difference in terms of operative outcomes (intraoperative blood loss and operative time) [7, 19, 20].
The results of our retrospective study indicate a shorter operative time and removal of larger tumors for TP. In terms of other parameters, such as time of hospitalization, intraoperative blood loss and perioperative complications, no significant difference occurred between the two approaches.
According to relevant literature data, the three key factors impacting operative time and the rate of conversions include obesity (BMI: > 24 kg/m2), tumors larger than 5 cm and the presence of pheochromocytomas [5, 21]. The retroperitoneal approach seems to be less effective in patients with increased BMI due to the relatively thick lumbar subcutaneous layer, which leads to less effective port placement and, thus, hampered and unsafe retroperitoneal manipulation. Although Zonca et al. claimed that RP is safe and effective even for patients with BMI values over 40 [22], most publications recommend TP for obese (BMI: > 30) patients [5].
Obesity may increase operative times as an independent predictive factor; however, in terms of BMI, similar results were obtained between the two groups. Among the 163 patients, 38 (28.14%) and 10 (35.71%) had a BMI ≥ 30 in cases of TP and RP, respectively (BMI: ≤ 25—TP vs. RP: n = 35 vs. n = 5; BMI: 25–30—TP vs. RP: n = 62 vs. n = 13; BMI: ≥ 30—TP vs. RP: n = 38 vs. n = 10) (Table 1.). Thus, no significant difference was noted, although high BMI values may have contributed to the prolonged LC in RP.
Malignant, hormonally active and large (6–10 cm) tumors were previously reserved for open surgery [7]. Conversely, our results confirmed that TP was indeed successful for large lesions (mean tumor size: 56.29 ± 9.02 mm), probably due to the wider operative working field and improved visualization.
The incidence of large, 6–10 cm adrenal tumors is 8.6–38.6%, showing malignancy in a quarter of the cases [23]. Tumor size shows direct correlation with chances of malignancy, although size is not always a reliable predictive factor. Even the most frequently occurring adenomas are often larger than 6 cm; hence, preoperative diagnostics [contrast-enhanced computed tomography (CT) and magnetic resonance imaging (MRI)] have a major impact on minimally invasive adrenalectomy and may suggest local or regional tumor involvement, thus influencing the surgical approach [24]. The laparoscopic approach was first proposed by Henry et al. for benign tumors under 4 cm and for non-invasive ones which do not exceed 12 cm [25]. This recommendation has greatly changed in recent decades, and, according to current ESES (European Society of Endocrine Surgeons) guidelines, the TP approach has been proven safe and oncologically sufficient for adrenocortical carcinomas not exceeding 10 cm [26]. Indeed, literature data reports successful removals of giant (> 10 cm), malignant lesions with the transperitoneal approach, which underlines the need for the expansion of indications [9]. In the surgical management of large, malignant adrenal tumors, oncological radicality, which maintains complete R0 resection, is of pivotal importance. Numerous studies support the choice of minimally invasive adrenalectomies in these cases, and, in terms of operative time and intraoperative blood loss, these studies report results that are at least comparable with the open method [9, 27]. The most time-consuming part in both methods is the dissection of tumor borders [28]. Analysis of the operative time-dependent efficacy showed that tumor size prolonged the operative time in TP cases, while this was true for tumor size and high BMI in RP cases [28]. In this respect, location and method of specimen removal may have affected the duration of surgery.
The dissected tumor may be retrieved through numerous locations, such as extended incisions of working ports (periumbilical, lateral), or through auxiliary incisions (pararectal, horizontal) and even a mini-Pfannenstiel incision. For TP, in cases involving large (6–10 cm) or extra-large (> 10 cm) adrenal lesions, we preferred the latter incision due to its excellent cosmesis and low rate of hernia development.
With regard to the presence of pheochromocytomas, minimally invasive removal of such lesions is often challenging. Numerous reports confirm that laparoscopic removal of pheochromocytomas can be carried out safely with a low morbidity rate [2931]. However, in terms of the RP approach, the surgical indications for large pheochromocytomas should be further investigated [32, 33].
Among the patients analyzed, pheochromocytomas occurred in 9 TP cases (6.66%) and 5 RP cases (17.85%), possibly influencing the rate of conversion, resulting in 6 (4.44%) and 5 (18%) converted patients for TP and RP, respectively. Regarding the removal of pheochromocytomas and the frequency of conversions, no conversion to open surgery was necessary in the TP group, while 2 conversions (40%) occurred during RP resections. The mean size of pheochromocytomas was 63.85 mm and 39.8 mm for TP and RP, respectively. Increased conversion rates in RP may have occurred due to the surgically more challenging and thus prolonged LC, a high proportion of patients (n = 10; 35.71%) with a BMI ≥ 30 kg/m2, and a high number of lesions that turned out to be hormonally active pheochromocytomas (n = 5; 17.8%).
Although previous abdominal surgery was significantly higher for TP [n = 61 (45.18%); p = 0.038], interestingly, our study found a conversion rate of 4.44% and 18% for TP and RP, respectively, which indicates no disadvantage for TP in terms of conversions. A similar phenomenon has been confirmed by other work groups as well; i.e., there is no evident and direct connection between previous abdominal surgery/adhesion formation and increased number of conversions [34, 35].
Direct access to the adrenals without incursion into intraabdominal organs ranks as the most important advantage of RP adrenalectomies, although a strong possibility of injuries may arise during blind dissection of the lesion and vasculature, leading to potentially severe collateral damage. According to Munch et al., when the opening of the abdominal cavity is avoided, the rate of postoperative ileus, bacterial infection and intestine-related complications may be decreased in RP [36]. In our case, no postoperative ileus occurred after 135 TP adrenalectomies. In terms of perioperative complications, the two groups showed no significant difference. In terms of early complications (1–2 days after surgery), splenic injury, fever, severe hyperkalemia, intraoperative bleeding and death due to ventricular fibrillation occurred with TP, while severe wound infection and intraoperative bleeding occurred in 2-2 RP cases. As a late onset complication (12–21 months after surgery), postoperative abdominal hernia developed in one TP patient (Table 4).
Following the initial dominance of the RP approach, we have gradually switched to the TP technique in recent years, as indicated by the significantly higher number of TP cases. Our goal was to compare both methods, and TP proved to be superior in terms of previous abdominal surgery, mean tumor size and mean operative time.
The present analysis has certain limitations, which is mainly due to its retrospective nature and low number of patients; however, the relatively high patient accrual and the analysis of the learning curve may increase the scientific value of these results. In terms of the LC, we noted results that significantly favored the TP approach (previous abdominal surgery, conversion rate and operative time). Based on these, we conclude that the learning time for TP is much shorter, especially for surgeons familiar with laparoscopy.

Conclusion

Both laparoscopic TP and RP adrenalectomies are safe and feasible, minimally invasive methods. According to our own results, RP adrenalectomy proved to be effective in the removal of smaller lesions, while TP adrenalectomy was shown to be more effective in the resection of large, extra-large and malignant lesions with a significantly shorter operative time. The analysis of the learning curve confirmed that TP can be carried out more rapidly, regardless of possible previous abdominal adhesions, thus resulting in lower conversion rates.

Acknowledgments

Open access funding provided by University of Szeged (SZTE).

Compliance with ethical standards

Disclosures

Aurel Ottlakan, Attila Paszt, Zsolt Simonka, Szabolcs Abraham, Bernadett Borda, Marton Vas, Bela Teleky, Adam Balogh and Gyorgy Lazar have no conflict of interest or financial ties to disclose.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Unsere Produktempfehlungen

Die Chirurgie

Print-Titel

Das Abo mit mehr Tiefe

Mit der Zeitschrift Die Chirurgie erhalten Sie zusätzlich Online-Zugriff auf weitere 43 chirurgische Fachzeitschriften, CME-Fortbildungen, Webinare, Vorbereitungskursen zur Facharztprüfung und die digitale Enzyklopädie e.Medpedia.

Bis 30. April 2024 bestellen und im ersten Jahr nur 199 € zahlen!

e.Med Interdisziplinär

Kombi-Abonnement

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

Literatur
1.
Zurück zum Zitat Gagner M, Pomp A, Heniford BT, Pharand D, Lacroix A (1997) Laparoscopic ad renalectomy lessons learned from 100 consecutive procedures. Ann Surg 226:238–247CrossRef Gagner M, Pomp A, Heniford BT, Pharand D, Lacroix A (1997) Laparoscopic ad renalectomy lessons learned from 100 consecutive procedures. Ann Surg 226:238–247CrossRef
2.
Zurück zum Zitat Mercan S, Seven R, Ozarmagan S, Tezelman S (1995) Endoscopic retroperitoneal adrenalectomy. Surgery 118(6):1071–1075 Mercan S, Seven R, Ozarmagan S, Tezelman S (1995) Endoscopic retroperitoneal adrenalectomy. Surgery 118(6):1071–1075
3.
Zurück zum Zitat Walz MK, Peitgen K, Krause U, Eigler FW (1995) Dorsal retroperitoneoscopic adrenalectomy—a new surgical technique. Zentralbl Chir 120:53–58 Walz MK, Peitgen K, Krause U, Eigler FW (1995) Dorsal retroperitoneoscopic adrenalectomy—a new surgical technique. Zentralbl Chir 120:53–58
4.
Zurück zum Zitat Walz MK, Alesina PF, Wenger FA, Koch JA, Neumann HP, Petersenn S, Schmid KW, Mann K (2006) Laparoscopic and retroperitoneoscopic treatment of pheochromocytomas and retroperitoneal paragangliomas: results of 161 tumors in 126 patients. World J Surg 30:899–908CrossRef Walz MK, Alesina PF, Wenger FA, Koch JA, Neumann HP, Petersenn S, Schmid KW, Mann K (2006) Laparoscopic and retroperitoneoscopic treatment of pheochromocytomas and retroperitoneal paragangliomas: results of 161 tumors in 126 patients. World J Surg 30:899–908CrossRef
5.
Zurück zum Zitat Lee CR, Walz MK, Park S, Park JH, Jeong JS, Lee SH, Kang SW, Jeong JJ, Nam KH, Chung WY, Park CS (2012) A comparative study of the transperitoneal and posterior retroperitoneal approaches for laparoscopic adrenalectomy for adrenal tumors. Ann Surg Oncol 19:2629–2634CrossRef Lee CR, Walz MK, Park S, Park JH, Jeong JS, Lee SH, Kang SW, Jeong JJ, Nam KH, Chung WY, Park CS (2012) A comparative study of the transperitoneal and posterior retroperitoneal approaches for laparoscopic adrenalectomy for adrenal tumors. Ann Surg Oncol 19:2629–2634CrossRef
6.
Zurück zum Zitat Mohammadi-Fallah MR, Mehdizadeh A, Badalzadeh A, Izadseresht B, Dadkhah N, Barbod A, Babaie M, Hamedanchi S (2013) Comparsion of transperitoneal versus retroperitoneal laparoscopic adrenalectomy in a prospective randomized study. J Laparoendosc Adv Surg Tech A 23:362–366CrossRef Mohammadi-Fallah MR, Mehdizadeh A, Badalzadeh A, Izadseresht B, Dadkhah N, Barbod A, Babaie M, Hamedanchi S (2013) Comparsion of transperitoneal versus retroperitoneal laparoscopic adrenalectomy in a prospective randomized study. J Laparoendosc Adv Surg Tech A 23:362–366CrossRef
7.
Zurück zum Zitat Tiberio GA, Solaini L, Arru L, Merigo G, Baiocchi GL, Giulini SM (2013) Factors influencing outcomes in laparoscopic adrenal surgery. Langenbecks Arch Surg 398:735–743CrossRef Tiberio GA, Solaini L, Arru L, Merigo G, Baiocchi GL, Giulini SM (2013) Factors influencing outcomes in laparoscopic adrenal surgery. Langenbecks Arch Surg 398:735–743CrossRef
8.
Zurück zum Zitat Mege D, Taieb D, Lowery A, Loundou A, Micco DE, C, Castinetti F, Morange I, Henry JF, Sebag F, (2014) Contemporary review of large adrenal tumors in a tertiary referral center. Anticancer Res 34(5):2581–2588 Mege D, Taieb D, Lowery A, Loundou A, Micco DE, C, Castinetti F, Morange I, Henry JF, Sebag F, (2014) Contemporary review of large adrenal tumors in a tertiary referral center. Anticancer Res 34(5):2581–2588
9.
Zurück zum Zitat Ottlakán A, Paszt A, Borda B, Simonka Z, Ábrahám S, Lázár G (2017) Removal of giant adrenal tumors using the laparoscopic transperitoneal technique. A report of three successful cases. Orv Hetil 158:1802–1807CrossRef Ottlakán A, Paszt A, Borda B, Simonka Z, Ábrahám S, Lázár G (2017) Removal of giant adrenal tumors using the laparoscopic transperitoneal technique. A report of three successful cases. Orv Hetil 158:1802–1807CrossRef
10.
Zurück zum Zitat Shonkwiler RJ, Lee JA (2011) Laparoscopic retroperitoneal adrenalectomy. Surg Laparosc Endosc Percutan Tech 21:243–247CrossRef Shonkwiler RJ, Lee JA (2011) Laparoscopic retroperitoneal adrenalectomy. Surg Laparosc Endosc Percutan Tech 21:243–247CrossRef
11.
Zurück zum Zitat Nigri G, Rosman AS, Petrucciani N, Fancellu A, Pisano M, Zorcolo L, Ramacciato G, Melis M (2013) Meta-analysis of trials comparing laparoscopic transperitoneal and retroperitoneal adrenalectomy. Surgery 153:111–119CrossRef Nigri G, Rosman AS, Petrucciani N, Fancellu A, Pisano M, Zorcolo L, Ramacciato G, Melis M (2013) Meta-analysis of trials comparing laparoscopic transperitoneal and retroperitoneal adrenalectomy. Surgery 153:111–119CrossRef
12.
Zurück zum Zitat Bonjer HJ, van der Harst E, Steyerberg EW, de Herder WW, Kazemier G, Mohammedamin RS, Bruining HA (1998) Retroperitoneal adrenalectomy: open or endoscopic? World J Surg 22:1246–1249CrossRef Bonjer HJ, van der Harst E, Steyerberg EW, de Herder WW, Kazemier G, Mohammedamin RS, Bruining HA (1998) Retroperitoneal adrenalectomy: open or endoscopic? World J Surg 22:1246–1249CrossRef
13.
Zurück zum Zitat Berber E, Tellioglu G, Harvey A, Mitchell J, Milas M, Siperstein A (2009) Comparison of laparoscopic transabdominal lateral versus posterior retroperitoneal adrenalectomy. Surgery 146:621–625CrossRef Berber E, Tellioglu G, Harvey A, Mitchell J, Milas M, Siperstein A (2009) Comparison of laparoscopic transabdominal lateral versus posterior retroperitoneal adrenalectomy. Surgery 146:621–625CrossRef
14.
Zurück zum Zitat Chen Y, Scholten A, Chomsky-Higgins K, Nwaogu I, Gosnell JE, Seib C, Shen WT, Suh I, Duh QY (2018) Risk factors associated with perioperative complications and prolonged length of stay after laparoscopic adrenalectomy. JAMA Surg 153:1036–1041CrossRef Chen Y, Scholten A, Chomsky-Higgins K, Nwaogu I, Gosnell JE, Seib C, Shen WT, Suh I, Duh QY (2018) Risk factors associated with perioperative complications and prolonged length of stay after laparoscopic adrenalectomy. JAMA Surg 153:1036–1041CrossRef
15.
Zurück zum Zitat Balogh Á, Varga L, Julesz J, Lázár G Jr, Martin K (2000) Minimally invasive adrenalectomy with posterior retroperitoneoscopy. Orv Hetil 141:845–848 Balogh Á, Varga L, Julesz J, Lázár G Jr, Martin K (2000) Minimally invasive adrenalectomy with posterior retroperitoneoscopy. Orv Hetil 141:845–848
16.
Zurück zum Zitat Lee J, El-Tamer M, Schifftner T, Turrentine FE, Henderson WG, Khuri S, Hanks JB (2008) Open and laparoscopic adrenalectomy: analysis of the National Surgical Quality Improvement Program. J Am Coll Surg 206:953–959CrossRef Lee J, El-Tamer M, Schifftner T, Turrentine FE, Henderson WG, Khuri S, Hanks JB (2008) Open and laparoscopic adrenalectomy: analysis of the National Surgical Quality Improvement Program. J Am Coll Surg 206:953–959CrossRef
17.
Zurück zum Zitat Hasegawa M, Miyajima A, Jinzaki M, Maeda T, Takeda T, Kikuchi E, Shibata H, Oya M (2013) Visceral fat is correlated with prolonged operative time in laparoendoscopic single-site adrenalectomy and laparoscopic adrenalectomy. Urology 82:1312–1318CrossRef Hasegawa M, Miyajima A, Jinzaki M, Maeda T, Takeda T, Kikuchi E, Shibata H, Oya M (2013) Visceral fat is correlated with prolonged operative time in laparoendoscopic single-site adrenalectomy and laparoscopic adrenalectomy. Urology 82:1312–1318CrossRef
18.
Zurück zum Zitat Constantinides VA, Christakis I, Touska P, Meeran K, Palazzo F (2013) Retroperitoneoscopic or laparoscopic adrenalectomy? A single-centre UK experience. Surg Endosc 27:4147–4152CrossRef Constantinides VA, Christakis I, Touska P, Meeran K, Palazzo F (2013) Retroperitoneoscopic or laparoscopic adrenalectomy? A single-centre UK experience. Surg Endosc 27:4147–4152CrossRef
19.
Zurück zum Zitat Elfenbein DM, Scarborough JE, Speicher PJ, Scheri RP (2013) Comparison of laparoscopic versus open adrenalectomy: results from American College of Surgeons-National Surgery Quality Improvement Project. J Surg Res 184:216–220CrossRef Elfenbein DM, Scarborough JE, Speicher PJ, Scheri RP (2013) Comparison of laparoscopic versus open adrenalectomy: results from American College of Surgeons-National Surgery Quality Improvement Project. J Surg Res 184:216–220CrossRef
20.
Zurück zum Zitat Conzo G, Musella M, Corcione F, De Palma M, Ferraro F, Palazzo A, Napolitano S, Milone M, Pasquali D, Sinisi AA, Colantuoni V, Santini L (2013) Laparoscopic adrenalectomy, a safe procedure for pheochromocytoma. A retrospective review of clinical series. Int J Surg 11:152–156CrossRef Conzo G, Musella M, Corcione F, De Palma M, Ferraro F, Palazzo A, Napolitano S, Milone M, Pasquali D, Sinisi AA, Colantuoni V, Santini L (2013) Laparoscopic adrenalectomy, a safe procedure for pheochromocytoma. A retrospective review of clinical series. Int J Surg 11:152–156CrossRef
21.
Zurück zum Zitat Shen ZJ, Chen SW, Wang S, Jin XD, Chen J, Zhu Y, Zhang RM (2007) Predictive factors for open conversion of laparoscopic adrenalectomy: a 13-year review of 456 cases. J Endourol 21:1333–1337CrossRef Shen ZJ, Chen SW, Wang S, Jin XD, Chen J, Zhu Y, Zhang RM (2007) Predictive factors for open conversion of laparoscopic adrenalectomy: a 13-year review of 456 cases. J Endourol 21:1333–1337CrossRef
22.
Zurück zum Zitat Zonča P, Bužga M, Ihnát P, Martínek L (2015) Retroperitoneoscopic adrenalectomy in obese patients: is it suitable? Obes Surg 25:1203–1208CrossRef Zonča P, Bužga M, Ihnát P, Martínek L (2015) Retroperitoneoscopic adrenalectomy in obese patients: is it suitable? Obes Surg 25:1203–1208CrossRef
23.
Zurück zum Zitat Shiraishi K, Kitahara S, Ito H, Oba K, Ohmi C, Matsuyama H (2019) Transperitoneal versus retroperitoneal laparoscopic adrenalectomy for large pheochromocytoma: comparative outcomes. Int J Urol 26:212–216CrossRef Shiraishi K, Kitahara S, Ito H, Oba K, Ohmi C, Matsuyama H (2019) Transperitoneal versus retroperitoneal laparoscopic adrenalectomy for large pheochromocytoma: comparative outcomes. Int J Urol 26:212–216CrossRef
24.
Zurück zum Zitat Gumbs AA, Gagner M (2006) Laparoscopic adrenalectomy. Best Practice & Research. Clin Endocrinol Metabol 20:483–499 Gumbs AA, Gagner M (2006) Laparoscopic adrenalectomy. Best Practice & Research. Clin Endocrinol Metabol 20:483–499
25.
Zurück zum Zitat Henry JF, Defechereux T, Gramatica L, Raffaelli M (1999) Should laparoscopic approach be proposed for large and/or potentially malignant adrenal tumors? Langenbecks Arch Surg 384:366–369CrossRef Henry JF, Defechereux T, Gramatica L, Raffaelli M (1999) Should laparoscopic approach be proposed for large and/or potentially malignant adrenal tumors? Langenbecks Arch Surg 384:366–369CrossRef
26.
Zurück zum Zitat Henry JF, Peix JL, Kraimps JL (2012) Positional statement of the European Society of Endocrine Surgeons (ESES) on malignant adrenal tumors. Langenbecks Arch Surg 397:145–146CrossRef Henry JF, Peix JL, Kraimps JL (2012) Positional statement of the European Society of Endocrine Surgeons (ESES) on malignant adrenal tumors. Langenbecks Arch Surg 397:145–146CrossRef
27.
Zurück zum Zitat Dalvi AN, Thapar PM, Thapar VB, Rege SA, Deshpande AA (2012) Laparoscopic adrenalectomy for large tumours: single team experience. J Minim Access Surg 8:125–128CrossRef Dalvi AN, Thapar PM, Thapar VB, Rege SA, Deshpande AA (2012) Laparoscopic adrenalectomy for large tumours: single team experience. J Minim Access Surg 8:125–128CrossRef
28.
Zurück zum Zitat Berber E, Duh QY, Clark OH, Siperstein AE (2002) A critical analysis of intraoperative time utilization in laparoscopic adrenalectomy. Surg Endosc 16:258–262CrossRef Berber E, Duh QY, Clark OH, Siperstein AE (2002) A critical analysis of intraoperative time utilization in laparoscopic adrenalectomy. Surg Endosc 16:258–262CrossRef
29.
Zurück zum Zitat Kercher KW, Novitsky YW, Park A, Matthews BD, Litwin DE, Heniford BT (2005) Laparoscopic curative resection of pheochromocytomas. Ann Surg 241:919–926CrossRef Kercher KW, Novitsky YW, Park A, Matthews BD, Litwin DE, Heniford BT (2005) Laparoscopic curative resection of pheochromocytomas. Ann Surg 241:919–926CrossRef
30.
Zurück zum Zitat Perry KA, El Youssef R, Pham TH, Sheppard BC (2010) Laparoscopic adrenalec-tomy for large unilateral pheochromocytoma: experience in a large academicmedical center. Surg Endosc 24:146–147 Perry KA, El Youssef R, Pham TH, Sheppard BC (2010) Laparoscopic adrenalec-tomy for large unilateral pheochromocytoma: experience in a large academicmedical center. Surg Endosc 24:146–147
31.
Zurück zum Zitat Boylu U, Oommen M, Lee BR, Thomas R (2009) Laparoscopic adrenalectomy forlarge adrenal masses: pushing the envelope. J Endourol 23:971–975CrossRef Boylu U, Oommen M, Lee BR, Thomas R (2009) Laparoscopic adrenalectomy forlarge adrenal masses: pushing the envelope. J Endourol 23:971–975CrossRef
32.
Zurück zum Zitat Wang B, Ma X, Li H, Shi T, Hu D, Fu B, Lang B, Chen G, Zhang X (2011) Anatomic retroperitoneoscopic adrenalectomy forseleted adrenal tumors >5 cm: our technique and experience. Urology 78(2): 348–352CrossRef Wang B, Ma X, Li H, Shi T, Hu D, Fu B, Lang B, Chen G, Zhang X (2011) Anatomic retroperitoneoscopic adrenalectomy forseleted adrenal tumors >5 cm: our technique and experience. Urology 78(2): 348–352CrossRef
33.
Zurück zum Zitat de Fourmestraux A, Salomon L, Abbou CC, Grise P (2015) Ten year experience of retroperitoneal laparoscopic resection for pheochromocytomas: a dual-centrestudy of 72 cases. World J Urol 33(8): 1103–1107CrossRef de Fourmestraux A, Salomon L, Abbou CC, Grise P (2015) Ten year experience of retroperitoneal laparoscopic resection for pheochromocytomas: a dual-centrestudy of 72 cases. World J Urol 33(8): 1103–1107CrossRef
34.
Zurück zum Zitat Mazeh H, Froyshteter AB, Wang TS, Amin AL, Evans DB, Sippel RS, Chen H, Yen TW (2012) Is previous same quadrant surgery a contraindication to laparoscopic adrenalectomy? Surgery 152:1211–1217CrossRef Mazeh H, Froyshteter AB, Wang TS, Amin AL, Evans DB, Sippel RS, Chen H, Yen TW (2012) Is previous same quadrant surgery a contraindication to laparoscopic adrenalectomy? Surgery 152:1211–1217CrossRef
35.
Zurück zum Zitat Economopoulos KP, Phitayakorn R, Lubitz CC, Sadow PM, Parangi S, Stephen AE, Hodin RA (2016) Should specific patient clinical characteristics discourage adrenal surgeons from performing laparoscopictransperitoneal adrenalectomy? Surgery 159:240–248CrossRef Economopoulos KP, Phitayakorn R, Lubitz CC, Sadow PM, Parangi S, Stephen AE, Hodin RA (2016) Should specific patient clinical characteristics discourage adrenal surgeons from performing laparoscopictransperitoneal adrenalectomy? Surgery 159:240–248CrossRef
36.
Zurück zum Zitat Munch LC, Gill IS, McRoberts JW (1994) Laparoscopic retroperitoneal renal cystectomy. J Urol 151:135–138CrossRef Munch LC, Gill IS, McRoberts JW (1994) Laparoscopic retroperitoneal renal cystectomy. J Urol 151:135–138CrossRef
Metadaten
Titel
Laparoscopic transperitoneal and retroperitoneal adrenalectomy: a 20-year, single-institution experience with an analysis of the learning curve and tumor size [lap transper and retroper adrenalectomy]
verfasst von
Aurel Ottlakan
Attila Paszt
Zsolt Simonka
Szabolcs Abraham
Bernadett Borda
Marton Vas
Bela Teleky
Adam Balogh
Gyorgy Lazar
Publikationsdatum
17.01.2020
Verlag
Springer US
Erschienen in
Surgical Endoscopy / Ausgabe 12/2020
Print ISSN: 0930-2794
Elektronische ISSN: 1432-2218
DOI
https://doi.org/10.1007/s00464-019-07337-1

Weitere Artikel der Ausgabe 12/2020

Surgical Endoscopy 12/2020 Zur Ausgabe

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Deutlich weniger Infektionen: Wundprotektoren schützen!

08.05.2024 Postoperative Wundinfektion Nachrichten

Der Einsatz von Wundprotektoren bei offenen Eingriffen am unteren Gastrointestinaltrakt schützt vor Infektionen im Op.-Gebiet – und dient darüber hinaus der besseren Sicht. Das bestätigt mit großer Robustheit eine randomisierte Studie im Fachblatt JAMA Surgery.

Chirurginnen und Chirurgen sind stark suizidgefährdet

07.05.2024 Suizid Nachrichten

Der belastende Arbeitsalltag wirkt sich negativ auf die psychische Gesundheit der Angehörigen ärztlicher Berufsgruppen aus. Chirurginnen und Chirurgen bilden da keine Ausnahme, im Gegenteil.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.